Investment in Genomics, Advanced Therapies, and Precision Health Offers New Opportunities for the UK MedTech Market

Investment in Genomics, Advanced Therapies, and Precision Health Offers New Opportunities for the UK MedTech Market

Innovation Culture in the Life Sciences Sector Enables Growth Despite the Short-term Impact of COVID-19 and Brexit

RELEASE DATE
30-Nov-2020
REGION
Europe
Research Code: MF68-01-00-00-00
SKU: HC03360-EU-MT_24993

$4,950.00

Special Price $4,207.50 save 15 %

In stock
SKU
HC03360-EU-MT_24993

$4,950.00

$4,207.50 save 15 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

The United Kingdom (UK) medical technology (MedTech) market is experiencing a transformational phase. Although it achieved steady growth up to 2019 and was infused with investments as part of the UK Life Sciences Sector Deal, market and regulatory challenges persist. In this research study, Frost & Sullivan analyzes the UK MedTech market landscape including discussion of trends, drivers, and restraints; and a forecast assessment. The study examines historical data on revenue turnover from the Office of Life Sciences and offers a forecast in consideration of several factors including Brexit; COVID-19; and the milestones earmarked in the UK Life Sciences Sector Deal, Life Sciences Recovery Roadmap, and other relevant strategic initiatives.

The study also identifies growth opportunities in light of recent market developments and presents an evaluation of the investments outlined by the Life Sciences Sector Deal. It covers the growth environment with specific focus on clusters within the UK MedTech sector.

Market segmentation is broken down into two main parts, MedTech core and services and supply, with MedTech core sub-segmented into medical devices, in-vitro diagnostics (IVD), and digital health. Revenue forecasts are provided for each segment. The study period is from 2015 to 2023.

Author: Shruthi Parakkal

Table of Contents

Purpose of this Experiential Study

Growth Opportunities Fuel the Growth Pipeline Engine™

Strategic Imperatives for Companies in the Market

UK MedTech Market—Segmentation and Definitions

UK MedTech Market—Market Segmentation Categories

UK MedTech Market—Market Segmentation Categories (continued)

UK MedTech Market—Competitive Landscape

UK MedTech Market—Key Performance Indicators

Drivers and Restraints

Market Forecast Methodology

UK MedTech Market Forecast

UK MedTech Market Forecast (continued)

UK MedTech Market Forecast (continued)

UK MedTech Market Forecast (continued)

UK MedTech Market Forecast (continued)

UK MedTech Market Forecast (continued)

UK MedTech Market Forecast (continued)

UK MedTech Market Forecast (continued)

UK MedTech Market Forecast (continued)

UK MedTech Market

UK MedTech Market Numbers

UK MedTech Market Numbers

COVID-19 Impact and Response

Macro to Micro Visioning

Trends and Factors Impacting the UK MedTech Market

Trends and Factors Impacting the UK MedTech Market (continued)

Trends and Factors Impacting the UK MedTech Market (continued)

Trends and Factors Impacting the UK MedTech Market (continued)

Trends and Factors Impacting the UK MedTech Market (continued)

Trends and Factors Impacting the UK MedTech Market (continued)

Top Predictions for the UK MedTech Market

Top Predictions for the UK MedTech Market (continued)

Opportunities across the UK Life Sciences Clusters

Identifying Clusters

Golden Triangle (Cambridge, Oxford, and London)

Identifying Clusters

North-West Cluster (Liverpool, Manchester, Leeds, and Sheffield)

Midlands Cluster (Birmingham, Nottingham, Leicester, Coventry, and Derby)

Northern Cluster (Edinburgh, Glasgow, Newcastle, and Durham)

South-West Cluster (Cardiff, Bristol, and Exeter)

Sutton (London and Surrey)

TEES Valley Cluster (Middlesbrough, Stockton-on-tees, and Darlington)

Levers for Growth

Introduction to Growth Opportunities

Assessing Short-term and Long-term Impacts on Growth Opportunities

Assessing Short-term and Long-term Impacts on Growth Opportunities (continued)

Growth Opportunity 1—Near Shoring of Product Development

Growth Opportunity 1—Near Shoring of Product Development (continued)

Growth Opportunity 2—Geographic Hotspots of Collaboration

Growth Opportunity 2—Geographic Hotspots of Collaboration (continued)

Growth Opportunity 2—Geographic Hotspots of Collaboration (continued)

Growth Opportunity 2—Geographic Hotspots of Collaboration (continued)

Growth Opportunity 3—Enhancing R&D Efficiency

Growth Opportunity 3—Enhancing R&D Efficiency (continued)

Growth Opportunity 3—Enhancing R&D Efficiency (continued)

Growth Opportunity 4—Manufacturing 4.0

Growth Opportunity 4—Manufacturing 4.0 (continued)

Growth Opportunity 4—Manufacturing 4.0 (continued)

Growth Opportunity 5—Digitalization

Growth Opportunity 5—Digitalization (continued)

Growth Opportunity 5—Digitalization (continued)

Legal Disclaimer

Research Methodology for Cluster Identification

Research Methodology for Cluster Identification (continued)

Data Sources

List of Exhibits

Related Research
The United Kingdom (UK) medical technology (MedTech) market is experiencing a transformational phase. Although it achieved steady growth up to 2019 and was infused with investments as part of the UK Life Sciences Sector Deal, market and regulatory challenges persist. In this research study, Frost & Sullivan analyzes the UK MedTech market landscape including discussion of trends, drivers, and restraints; and a forecast assessment. The study examines historical data on revenue turnover from the Office of Life Sciences and offers a forecast in consideration of several factors including Brexit; COVID-19; and the milestones earmarked in the UK Life Sciences Sector Deal, Life Sciences Recovery Roadmap, and other relevant strategic initiatives. The study also identifies growth opportunities in light of recent market developments and presents an evaluation of the investments outlined by the Life Sciences Sector Deal. It covers the growth environment with specific focus on clusters within the UK MedTech sector. Market segmentation is broken down into two main parts, MedTech core and services and supply, with MedTech core sub-segmented into medical devices, in-vitro diagnostics (IVD), and digital health. Revenue forecasts are provided for each segment. The study period is from 2015 to 2023. Author: Shruthi Parakkal
More Information
No Index No
Podcast No
Author Shruthi Parakkal
Industries Healthcare
WIP Number MF68-01-00-00-00
Is Prebook No
GPS Codes 9575-B1,9600-B1,9612-B1,9570-B1,9573-B1,9A48-B1,9A4B-B1,9614-B1,9627-B1